Impact of Gender-Specific Human Papillomavirus Vaccine Recommendations on Uptake of Other Adolescent Vaccines: Analysis of the NIS-Teen (2008-2012).
In the United States, human papillomavirus vaccination was routinely recommended for adolescent females in 2006 and provisionally recommended for adolescent males in 2009. We evaluated the hypothesis that gender-specific human papillomavirus vaccination recommendations would impact gender-specific uptake of other vaccines using National Immunization Survey-Teen public use data sets (2008-2012). Female adolescents had higher coverage than males of at least 1 other adolescent vaccine in 2008 (3.0% higher) and 2009 (4.3% higher). Gender differences abated in 2010, 2011, and 2012 (0.2%, 0.9%, and 0.4%, respectively). To evaluate unintended consequences of gender-based recommendations, countries with female-only human papillomavirus vaccination recommendations should evaluate gender-specific uptake of other adolescent vaccines.
Department of Global Health and Epidemiology, Emory University, Rollins School of Public Health; Emory Vaccine Center; and Cancer Prevention and Control Program, Winship Cancer Institute, Atlanta, Georgia (Dr Bednarczyk); Emory Vaccine Center, and School of Medicine, Infectious Disease, Atlanta, Georgia (Dr Orenstein); and Department of Global Health and Epidemiology, Emory University, Rollins School of Public Health; Department of Pediatrics, School of Medicine, Emory University; and Emory Vaccine Center, Atlanta, Georgia (Dr Omer).
Robert A
RA
Bednarczyk
Walter A
WA
Orenstein
Saad B
SB
Omer
D000293:Adolescent; D005260:Female; D006287:Health Planning Guidelines; D006801:Humans; D008297:Male; D055118:Medication Adherence; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use; D012737:Sex Factors; D011795:Surveys and Questionnaires; D014481:United States
D053918:Papillomavirus Vaccines